Jennifer Rocnik, Ph.D.
Dr. Jennifer Rocnik is Vice President, Discovery Biology at Constellation. Jenn has more than a dozen years of drug discovery experience in both Biotech and Pharma where she has led programs from target identification to Development Candidate nomination. Prior to joining Constellation, Jenn was at Nimbus Therapeutics where she most recently served as Vice President of Biology and was responsible for leading Nimbus’ programs in Oncology and Immuno-Oncology and overseeing efforts to identify new targets across the portfolio. Previously, Jenn held roles of increasing responsibility in the Oncology division of Sanofi where she led cross-functional global drug discovery project teams and Novartis Institutes for Biomedical Research where she led a number of Oncology target validation and early drug discovery programs. Jenn received her Ph.D. in Molecular Medicine from Boston University School of Medicine and completed her postdoctoral fellowship at Brigham and Women’s Hospital.